Add like
Add dislike
Add to saved papers

Study on a set of bis-cyclometalated Ir(III) complexes with a common ancillary ligand.

Bis-cyclometalated iridium(III) complexes [Ir(F2ppy)2ZN] (FZN), [Ir(F2CNppy)2ZN] (FCZN), [Ir(DMAF2ppy)2ZN] (FDZN) and [Ir(MeOF2ppy)2ZN] (MeOFZN) (F2ppy = 4',6'-difluoro-2-phenylpyridinate, F2CNppy = 5-cyano-4',6'-difluoro-2-phenylpyridinate, DMAF2ppy = 4',6'-difluoro-4-dimethylamino-2-phenylpyridinate, MeOF2ppy = 4',6'-difluoro-4-methyl-2-phenylpyridinate and ZN = 3,5-dimethylpyrazole-N-carboxamide) emitting in the sky blue region were synthesized. We studied the effect of the ancillary ligand ZN and the substituents on the cyclometalating ligands on the crystal structures, photophysical and electrochemical properties and the frontier orbitals. Density functional theory (DFT) calculation results indicate that in FCZN and FDZN the cyclometalating ligands show negligible participation in the HOMO, the ancillary ligand ZN being the main participant along with the Ir(III) d-orbitals. MeOFZN exhibits the maximum photoluminescence quantum efficiency and radiative emission rates along with the dominant low frequency metal-ligand vibrations and maximum reorganization energy in the excited state. All the substituted complexes show more polar characteristics than FZN, FCZN possessing the highest dipole moment among the complexes. The performances of the solution-synthesised organic light emitting devices (OLEDs) of FZN, FCZN and FDZN doped in a blend of mCP (m-bis(N-carbazolylbenzene)) and polystyrene are studied.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app